Guided Therapeutics Inc (GTHP) income statement
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 75.8%
- Operating margin
- -303.8%
- Net margin
- -471.5%
- Return on equity, FY2025
- 58.7%
Financial strength
- Current ratio
- 0.09
- Debt to equity
- -0.00
- Debt to assets
- 0.9%
- Cash to current liabilities
- 0.2%
Valuation
- P/E ratio
- –
- Price to sales
- 23.76
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?